T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope

被引:63
作者
Hombach, A
Heuser, C
Sircar, R
Tillmann, T
Diehl, V
Kruis, W
Pohl, C
Abken, H
机构
[1] UNIV COLOGNE,INNERE MED KLIN 1,D-50924 COLOGNE,GERMANY
[2] EVANGEL KRANKENHAUS KOLN,COLOGNE,GERMANY
关键词
D O I
10.1053/gast.1997.v113.pm9322511
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Chimeric receptors with specificity for defined tumor antigens are valuable tools for targeting cytolytic T cells specifically to tumor cells, The aim of this study, for the situation of gastrointestinal cancer, was to investigate the generation of a chimeric T cell receptor that specifically binds the tumor antigen TAG72 (CA72-4) and transmits a signal for cellular activation, Methods: A single-chain antibody (scFv) was derived from the monoclonal anti-TAG72 antibody B72.3 by phage display techniques (B72.3-scFv) and fused to the signaling unit of the Fc epsilon-RI receptor gamma chain, resulting in a chimeric signaling receptor, B72.3-scFv-gamma, Results: The B72.3-scFv and the chimeric B72.3-scFv-gamma receptor bound specifically to the TAG72 antigen, After transfection, T cells expressing the chimeric B72.3-scFv-gamma specifically recognized TAG72 positive cells, Cross-linking of the chimeric receptor with antigen resulted in interleukin 2 release and cytolytic activity against TAG72 positive tumor cells in vitro. Conclusions: T cells equipped with the chimeric anti-TAG72 receptor can be specifically activated to target and lyse TAG72 positive gastrointestinal tumor cells.
引用
收藏
页码:1163 / 1170
页数:8
相关论文
共 44 条
  • [1] Chimeric T-cell receptors: Highly specific tools to target cytotoxic T-lymphocytes to tumour cells
    Abken, H
    Hombach, A
    Heuser, C
    Sircar, R
    Pohl, C
    Reinhold, U
    [J]. CANCER TREATMENT REVIEWS, 1997, 23 (02) : 97 - 112
  • [2] BATEMAN WJ, 1995, CANCER IMMUNOL IMMUN, V41, P61, DOI 10.1007/BF01788961
  • [3] FLUORESCENT EUROPIUM CHELATES AS TARGET-CELL MARKERS IN THE ASSESSMENT OF NATURAL-KILLER-CELL CYTOTOXICITY
    BLOMBERG, K
    ULFSTEDT, AC
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 160 (01) : 27 - 34
  • [4] T-CELL TARGETING IN CANCER-THERAPY
    BOLHUIS, RLH
    STURM, E
    BRAAKMAN, E
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 34 (01) : 1 - 8
  • [5] MAKING ANTIBODY FRAGMENTS USING PHAGE DISPLAY LIBRARIES
    CLACKSON, T
    HOOGENBOOM, HR
    GRIFFITHS, AD
    WINTER, G
    [J]. NATURE, 1991, 352 (6336) : 624 - 628
  • [6] In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes - Results of a double gene marking trial
    Economou, JS
    Belldegrun, AS
    Glaspy, J
    Toloza, EM
    Figlin, R
    Hobbs, J
    Meldon, N
    Kaboo, R
    Tso, CL
    Miller, A
    Lau, R
    McBride, W
    Moen, RC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) : 515 - 521
  • [7] SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS
    ESHHAR, Z
    WAKS, T
    GROSS, G
    SCHINDLER, DG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) : 720 - 724
  • [8] FINER MH, 1994, BLOOD, V83, P43
  • [9] ANTITUMOR MONOCLONAL-ANTIBODIES GENERATED BY IMMUNIZATION WITH MUCINS
    GILLETTE, RW
    SINGLETON, J
    GUILLEN, D
    GILMAN, SC
    [J]. HYBRIDOMA, 1991, 10 (05): : 583 - 594
  • [10] MONOCLONAL-ANTIBODY B72.3 REACTS WITH A CORE REGION STRUCTURE OF O-LINKED CARBOHYDRATES
    GOLD, DV
    MATTES, MJ
    [J]. TUMOR BIOLOGY, 1988, 9 (2-3) : 137 - 144